GEN1
Basic information
Region (hg38): 2:17753858-17788946
Links
Phenotypes
GenCC
Source:
- familial ovarian cancer (No Known Disease Relationship), mode of inheritance: AD
- hereditary breast carcinoma (Refuted Evidence), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GEN1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 126 | 133 | ||||
missense | 361 | 12 | 10 | 383 | ||
nonsense | 13 | 13 | ||||
start loss | 0 | |||||
frameshift | 28 | 29 | ||||
inframe indel | 8 | |||||
splice donor/acceptor (+/-2bp) | 9 | |||||
splice region | 10 | 11 | 2 | 23 | ||
non coding | 35 | 44 | 81 | |||
Total | 0 | 0 | 424 | 173 | 59 |
Variants in GEN1
This is a list of pathogenic ClinVar variants found in the GEN1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-17754138-G-T | Hereditary cancer-predisposing syndrome | Likely benign (Dec 01, 2015) | ||
2-17755795-A-T | Hereditary cancer-predisposing syndrome | Likely benign (Dec 01, 2015) | ||
2-17755897-T-G | Hereditary cancer-predisposing syndrome | Likely benign (Dec 01, 2015) | ||
2-17757644-A-T | Hereditary cancer-predisposing syndrome | Likely benign (Dec 01, 2015) | ||
2-17758468-T-C | Hereditary cancer-predisposing syndrome | Likely benign (Dec 01, 2015) | ||
2-17759914-T-G | Hereditary cancer-predisposing syndrome | Likely benign (Dec 01, 2015) | ||
2-17759951-T-C | Uncertain significance (Dec 05, 2021) | |||
2-17759955-T-A | Uncertain significance (Mar 27, 2022) | |||
2-17759959-T-G | not specified | Uncertain significance (Nov 22, 2024) | ||
2-17759961-G-A | Likely benign (Feb 02, 2021) | |||
2-17759965-C-A | not specified | Uncertain significance (Jan 17, 2024) | ||
2-17759968-A-G | Uncertain significance (Dec 08, 2022) | |||
2-17759985-G-A | not specified | Likely benign (Nov 26, 2024) | ||
2-17759991-C-A | Uncertain significance (Nov 10, 2021) | |||
2-17759992-A-G | Uncertain significance (Feb 02, 2023) | |||
2-17759997-C-G | Likely benign (Jan 01, 2023) | |||
2-17760001-C-T | not specified | Uncertain significance (Dec 08, 2024) | ||
2-17760002-G-A | Uncertain significance (Jan 07, 2023) | |||
2-17760002-G-T | not specified | Uncertain significance (Nov 27, 2024) | ||
2-17760027-A-T | not specified | Likely benign (Nov 30, 2024) | ||
2-17760028-G-A | not specified | Uncertain significance (Dec 08, 2024) | ||
2-17760028-G-C | Uncertain significance (Apr 23, 2020) | |||
2-17760040-C-G | not specified | Uncertain significance (Dec 08, 2024) | ||
2-17760048-G-T | not specified | Likely benign (Nov 20, 2024) | ||
2-17760054-G-A | Likely benign (Apr 22, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GEN1 | protein_coding | protein_coding | ENST00000381254 | 13 | 31508 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.73e-15 | 0.693 | 104901 | 1034 | 19813 | 125748 | 0.0866 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0999 | 451 | 457 | 0.987 | 0.0000217 | 5996 |
Missense in Polyphen | 110 | 120.21 | 0.91507 | 1548 | ||
Synonymous | 0.261 | 157 | 161 | 0.974 | 0.00000763 | 1640 |
Loss of Function | 1.81 | 29 | 41.6 | 0.698 | 0.00000208 | 558 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0622 | 0.0623 |
Ashkenazi Jewish | 0.0993 | 0.0989 |
East Asian | 0.126 | 0.128 |
Finnish | 0.0939 | 0.0944 |
European (Non-Finnish) | 0.113 | 0.112 |
Middle Eastern | 0.126 | 0.128 |
South Asian | 0.0476 | 0.0473 |
Other | 0.0908 | 0.0909 |
dbNSFP
Source:
- Function
- FUNCTION: Endonuclease which resolves Holliday junctions (HJs) by the introduction of symmetrically related cuts across the junction point, to produce nicked duplex products in which the nicks can be readily ligated. Four-way DNA intermediates, also known as Holliday junctions, are formed during homologous recombination and DNA repair, and their resolution is necessary for proper chromosome segregation (PubMed:19020614, PubMed:26682650). Cleaves HJs by a nick and counter-nick mechanism involving dual coordinated incisions that lead to the formation of ligatable nicked duplex products. Cleavage of the first strand is rate limiting, while second strand cleavage is rapid. Largely monomeric, dimerizes on the HJ and the first nick occurs upon dimerization at the junction (PubMed:26578604). Efficiently cleaves both single and double HJs contained within large recombination intermediates. Exhibits a weak sequence preference for incision between two G residues that reside in a T-rich region of DNA (PubMed:28049850). Has also endonuclease activity on 5'- flap and replication fork (RF) DNA substrates (PubMed:26578604). {ECO:0000269|PubMed:19020614, ECO:0000269|PubMed:26578604, ECO:0000269|PubMed:26682650, ECO:0000269|PubMed:28049850}.;
- Pathway
- HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);DNA Repair;DNA Double-Strand Break Repair;Homology Directed Repair;Resolution of D-loop Structures through Holliday Junction Intermediates;Resolution of D-Loop Structures;HDR through Homologous Recombination (HRR)
(Consensus)
Recessive Scores
- pRec
- 0.0983
Intolerance Scores
- loftool
- 0.994
- rvis_EVS
- 2.2
- rvis_percentile_EVS
- 98.13
Haploinsufficiency Scores
- pHI
- 0.0998
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.471
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.110
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gen1
- Phenotype
Gene ontology
- Biological process
- double-strand break repair via homologous recombination;regulation of centrosome duplication;replication fork processing;resolution of recombination intermediates;resolution of mitotic recombination intermediates;positive regulation of mitotic cell cycle spindle assembly checkpoint
- Cellular component
- nucleoplasm;centrosome
- Molecular function
- magnesium ion binding;four-way junction DNA binding;endodeoxyribonuclease activity;crossover junction endodeoxyribonuclease activity;5'-flap endonuclease activity;5'-3' exodeoxyribonuclease activity;protein homodimerization activity;flap endonuclease activity